Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 48.7
(-4.58%)
CNY 48.7
(-4.58%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 75.17 Million CNY | -94.47% |
| 2022 | 1.35 Billion CNY | 797.03% |
| 2021 | 151.58 Million CNY | -90.54% |
| 2020 | 1.6 Billion CNY | 281.47% |
| 2019 | 419.84 Million CNY | -35.89% |
| 2018 | 654.88 Million CNY | 23.92% |
| 2017 | 528.47 Million CNY | 1116.9% |
| 2016 | 43.42 Million CNY | 332.98% |
| 2015 | 10.03 Million CNY | 0.3% |
| 2014 | 10 Million CNY | -50.0% |
| 2013 | 20 Million CNY | 100.0% |
| 2012 | 10 Million CNY | -50.0% |
| 2011 | 20 Million CNY | 0.0% |
| 2010 | 20 Million CNY | 100.0% |
| 2009 | 10 Million CNY | 0.0% |
| 2008 | - CNY | -100.0% |
| 2007 | 60 Million CNY | 25.0% |
| 2006 | 48 Million CNY | 0.0% |
| 2005 | 48 Million CNY | -51.52% |
| 2004 | 99 Million CNY | -73.95% |
| 2003 | 380.07 Million CNY | 48.18% |
| 2002 | 256.5 Million CNY | 1.83% |
| 2001 | 251.9 Million CNY | 37.89% |
| 2000 | 182.68 Million CNY | 2.59% |
| 1999 | 178.07 Million CNY | 44.21% |
| 1998 | 123.48 Million CNY | 10.23% |
| 1997 | 112.02 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 78.39 Million CNY | 4.29% |
| 2024 Q2 | 487.55 Million CNY | 521.9% |
| 2024 Q3 | 36.27 Million CNY | -89.48% |
| 2023 Q4 | 75.17 Million CNY | -16.36% |
| 2023 Q1 | 93.91 Million CNY | -93.09% |
| 2023 Q2 | 86.87 Million CNY | -7.49% |
| 2023 FY | 75.17 Million CNY | -94.47% |
| 2023 Q3 | 89.88 Million CNY | 3.46% |
| 2022 Q1 | 143.74 Million CNY | -5.17% |
| 2022 Q3 | 147.27 Million CNY | 11.85% |
| 2022 FY | 1.35 Billion CNY | 797.03% |
| 2022 Q4 | 1.35 Billion CNY | 823.31% |
| 2022 Q2 | 131.67 Million CNY | -8.4% |
| 2021 Q3 | 49.97 Million CNY | -3.52% |
| 2021 Q4 | 151.58 Million CNY | 203.36% |
| 2021 Q1 | 47.17 Million CNY | 0.0% |
| 2021 FY | 151.58 Million CNY | -90.54% |
| 2021 Q2 | 51.79 Million CNY | 9.79% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 FY | 1.6 Billion CNY | 281.47% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 FY | 419.84 Million CNY | -35.89% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 FY | 654.88 Million CNY | 23.92% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 FY | 528.47 Million CNY | 1116.9% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2016 Q2 | 10.03 Million CNY | 0.0% |
| 2016 FY | 43.42 Million CNY | 332.98% |
| 2016 Q3 | 10.03 Million CNY | 0.0% |
| 2016 Q1 | 10.03 Million CNY | 0.0% |
| 2016 Q4 | - CNY | -100.0% |
| 2015 FY | 10.03 Million CNY | 0.3% |
| 2015 Q4 | 10.03 Million CNY | 0.3% |
| 2015 Q1 | 10 Million CNY | 0.0% |
| 2015 Q2 | 10 Million CNY | 0.0% |
| 2015 Q3 | 10 Million CNY | 0.0% |
| 2014 Q1 | 20 Million CNY | 0.0% |
| 2014 Q3 | 20 Million CNY | 0.0% |
| 2014 Q2 | 20 Million CNY | 0.0% |
| 2014 Q4 | 10 Million CNY | -50.0% |
| 2014 FY | 10 Million CNY | -50.0% |
| 2013 Q1 | 10 Million CNY | 0.0% |
| 2013 Q2 | 10 Million CNY | 0.0% |
| 2013 Q3 | 10 Million CNY | 0.0% |
| 2013 Q4 | 20 Million CNY | 100.0% |
| 2013 FY | 20 Million CNY | 100.0% |
| 2012 Q2 | 20 Million CNY | 0.0% |
| 2012 Q1 | 20 Million CNY | 0.0% |
| 2012 Q4 | 10 Million CNY | 0.0% |
| 2012 FY | 10 Million CNY | -50.0% |
| 2012 Q3 | 10 Million CNY | -50.0% |
| 2011 FY | 20 Million CNY | 0.0% |
| 2011 Q4 | 20 Million CNY | -0.15% |
| 2011 Q3 | 20.03 Million CNY | 0.0% |
| 2011 Q2 | 20.03 Million CNY | 0.15% |
| 2011 Q1 | 20 Million CNY | 0.0% |
| 2010 Q2 | 10 Million CNY | 0.0% |
| 2010 Q4 | 20 Million CNY | 99.5% |
| 2010 FY | 20 Million CNY | 100.0% |
| 2010 Q3 | 10.02 Million CNY | 0.25% |
| 2010 Q1 | 10 Million CNY | 0.0% |
| 2009 FY | 10 Million CNY | 0.0% |
| 2009 Q3 | - CNY | 0.0% |
| 2009 Q1 | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2009 Q4 | 10 Million CNY | 0.0% |
| 2008 Q3 | - CNY | 0.0% |
| 2008 FY | - CNY | -100.0% |
| 2008 Q1 | - CNY | -100.0% |
| 2008 Q2 | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2007 Q4 | 60 Million CNY | 0.0% |
| 2007 Q3 | 60 Million CNY | 0.0% |
| 2007 Q2 | 60 Million CNY | 25.0% |
| 2007 Q1 | 48 Million CNY | 0.0% |
| 2007 FY | 60 Million CNY | 25.0% |
| 2006 Q1 | 48 Million CNY | 0.0% |
| 2006 Q2 | 48 Million CNY | 0.0% |
| 2006 Q3 | 48 Million CNY | 0.0% |
| 2006 FY | 48 Million CNY | 0.0% |
| 2006 Q4 | 48 Million CNY | 0.0% |
| 2005 Q1 | 63 Million CNY | -36.36% |
| 2005 FY | 48 Million CNY | -51.52% |
| 2005 Q2 | 26 Million CNY | -58.73% |
| 2005 Q3 | 48 Million CNY | 84.62% |
| 2005 Q4 | 48 Million CNY | 0.0% |
| 2004 Q1 | 256 Million CNY | -32.64% |
| 2004 Q3 | 88 Million CNY | -57.61% |
| 2004 Q4 | 99 Million CNY | 12.5% |
| 2004 Q2 | 207.6 Million CNY | -18.91% |
| 2004 FY | 99 Million CNY | -73.95% |
| 2003 Q4 | 380.07 Million CNY | -1.57% |
| 2003 Q1 | 342 Million CNY | 33.33% |
| 2003 Q3 | 386.13 Million CNY | -1.35% |
| 2003 Q2 | 391.43 Million CNY | 14.46% |
| 2003 FY | 380.07 Million CNY | 48.18% |
| 2002 Q2 | 261.2 Million CNY | -7.67% |
| 2002 Q1 | 282.9 Million CNY | 12.31% |
| 2002 FY | 256.5 Million CNY | 1.83% |
| 2002 Q4 | 256.5 Million CNY | -5.25% |
| 2002 Q3 | 270.7 Million CNY | 3.64% |
| 2001 FY | 251.9 Million CNY | 37.89% |
| 2001 Q2 | 215.18 Million CNY | 0.0% |
| 2001 Q4 | 251.9 Million CNY | 0.0% |
| 2000 Q4 | 182.68 Million CNY | 0.0% |
| 2000 FY | 182.68 Million CNY | 2.59% |
| 1999 FY | 178.07 Million CNY | 44.21% |
| 1998 FY | 123.48 Million CNY | 10.23% |
| 1997 FY | 112.02 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.33 Billion CNY | 94.36% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.03 Billion CNY | 92.744% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 405.85 Million CNY | 81.477% |
| Aurora Optoelectronics Co.,Ltd. | 29.86 Million CNY | -151.687% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 114.76 Million CNY | 34.496% |
| NanJing Pharmaceutical Company Limited | 11.61 Billion CNY | 99.353% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 291.35 Million CNY | 74.198% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 150 Million CNY | 49.882% |